Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer
The aim of this study was to assess the prognostic value of deoxyribonucleic acid analysis, expression oferbB1, erbB2 and P53, and amplification levels of erbB1, erbB2 and erbB3 in non-small cell lung cancer (NSCLC). Consecutive patients with NSCLC who underwent treatment with curative intention (11...
Gespeichert in:
| Veröffentlicht in: | The European respiratory journal 2000-11, Vol.16 (5), p.991-996 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 996 |
|---|---|
| container_issue | 5 |
| container_start_page | 991 |
| container_title | The European respiratory journal |
| container_volume | 16 |
| creator | Reinmuth, N Brandt, B Kunze, WP Junker, K Thomas, M Achatzy, R Scheld, HH Semik, M |
| description | The aim of this study was to assess the prognostic value of deoxyribonucleic acid analysis, expression oferbB1, erbB2 and P53, and amplification levels of erbB1, erbB2 and erbB3 in non-small cell lung cancer (NSCLC). Consecutive patients with NSCLC who underwent treatment with curative intention (118) were included. In 108 cases, the cell cycle was analysed using flow cytometry and double-staining with propidium iodide and anticytokeratin. In another 108 cases, expression of erbB1, erbB2 and P53 was assessed immunhistochemically. Amplification of the erbB family was determined in the tumours of 53 patients using double-differential polymerase chain reaction. Of the tumours, 81% were aneuploid and 14% showed positive staining for erbB1, 18% for erbB2 and 41% for P53. There were normal mean gene copy numbers in 86% for erbB1, 94% for erbB2 and in 96% for erbB3. No significant correlations were noted between erbB1, erbB2 and P53 expression, ploidy status and tumour stage. In a Cox regression model, only tumour stage was shown to be prognostically significant. It seems that ploidy and expression status of erbB1, erbB2 and P53 are not prognostic parameters in non-small cell lung cancer. Amplification of the erbB family does not seem to be a frequent event in non-small cell lung cancer. |
| doi_str_mv | 10.1183/09031936.00.16599100 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72524755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72524755</sourcerecordid><originalsourceid>FETCH-LOGICAL-c407t-bbe8805ef4d13b9764977d2c4138e190bb84edcb663eb4de065d325e702993713</originalsourceid><addsrcrecordid>eNptkE1v1DAQhi0EokvhHyBkCcFpU2bij8RHqPiSKtEDnC3bmbSu8rG1dwX99zi7AS5cPNbomXfsh7GXCBeIrXgHBgQaoS-gNLQyBgEesQ0KYyoBIB6zzYJUC3PGnuV8B4BaCnzKzhBRCQ1qw-6vhzl2D1tOv3aJco7zxOeeU_IfcHss9ZZfK8Hd1HE37obYx-D2_8GOxHITPE58mqcqj24YeKByDIfphgc3BUrP2ZPeDZlerPWc_fj08fvll-rq2-evl--vqiCh2VfeU9uCol52KLxptDRN09VBomgJDXjfSuqC11qQlx2BVp2oFTVQGyMaFOfs7Sl3l-b7A-W9HWNeHuMmmg_ZNrWqZaNUAeUJDGnOOVFvdymOLj1YBLuotn9UWyiNVXUZe7XmH_xI3b-h1W0BXq-Ay8ENfSrfj_kv10rV6rpQb07Ubby5_RkT2aO2EoqW0h1qq2xZKH4DMeKPmw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72524755</pqid></control><display><type>article</type><title>Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Reinmuth, N ; Brandt, B ; Kunze, WP ; Junker, K ; Thomas, M ; Achatzy, R ; Scheld, HH ; Semik, M</creator><creatorcontrib>Reinmuth, N ; Brandt, B ; Kunze, WP ; Junker, K ; Thomas, M ; Achatzy, R ; Scheld, HH ; Semik, M</creatorcontrib><description>The aim of this study was to assess the prognostic value of deoxyribonucleic acid analysis, expression oferbB1, erbB2 and P53, and amplification levels of erbB1, erbB2 and erbB3 in non-small cell lung cancer (NSCLC). Consecutive patients with NSCLC who underwent treatment with curative intention (118) were included. In 108 cases, the cell cycle was analysed using flow cytometry and double-staining with propidium iodide and anticytokeratin. In another 108 cases, expression of erbB1, erbB2 and P53 was assessed immunhistochemically. Amplification of the erbB family was determined in the tumours of 53 patients using double-differential polymerase chain reaction. Of the tumours, 81% were aneuploid and 14% showed positive staining for erbB1, 18% for erbB2 and 41% for P53. There were normal mean gene copy numbers in 86% for erbB1, 94% for erbB2 and in 96% for erbB3. No significant correlations were noted between erbB1, erbB2 and P53 expression, ploidy status and tumour stage. In a Cox regression model, only tumour stage was shown to be prognostically significant. It seems that ploidy and expression status of erbB1, erbB2 and P53 are not prognostic parameters in non-small cell lung cancer. Amplification of the erbB family does not seem to be a frequent event in non-small cell lung cancer.</description><identifier>ISSN: 0903-1936</identifier><identifier>EISSN: 1399-3003</identifier><identifier>DOI: 10.1183/09031936.00.16599100</identifier><identifier>PMID: 11153605</identifier><language>eng</language><publisher>Leeds: Eur Respiratory Soc</publisher><subject>Adenocarcinoma - genetics ; Adenocarcinoma - pathology ; Adult ; Aged ; Biological and medical sciences ; Carcinoma, Large Cell - genetics ; Carcinoma, Large Cell - pathology ; Carcinoma, Non-Small-Cell Lung - genetics ; Carcinoma, Non-Small-Cell Lung - pathology ; Carcinoma, Squamous Cell - genetics ; Carcinoma, Squamous Cell - pathology ; Female ; Gene Amplification ; Gene Expression ; Genes, erbB ; Genes, erbB-1 ; Genes, erbB-2 ; Genes, p53 ; Humans ; Lung Neoplasms - genetics ; Lung Neoplasms - pathology ; Male ; Medical sciences ; Middle Aged ; Neoplasm Staging ; Ploidies ; Pneumology ; Prognosis ; Prospective Studies ; Receptor, ErbB-3 - genetics ; Tumors of the respiratory system and mediastinum</subject><ispartof>The European respiratory journal, 2000-11, Vol.16 (5), p.991-996</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c407t-bbe8805ef4d13b9764977d2c4138e190bb84edcb663eb4de065d325e702993713</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=845862$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11153605$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reinmuth, N</creatorcontrib><creatorcontrib>Brandt, B</creatorcontrib><creatorcontrib>Kunze, WP</creatorcontrib><creatorcontrib>Junker, K</creatorcontrib><creatorcontrib>Thomas, M</creatorcontrib><creatorcontrib>Achatzy, R</creatorcontrib><creatorcontrib>Scheld, HH</creatorcontrib><creatorcontrib>Semik, M</creatorcontrib><title>Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer</title><title>The European respiratory journal</title><addtitle>Eur Respir J</addtitle><description>The aim of this study was to assess the prognostic value of deoxyribonucleic acid analysis, expression oferbB1, erbB2 and P53, and amplification levels of erbB1, erbB2 and erbB3 in non-small cell lung cancer (NSCLC). Consecutive patients with NSCLC who underwent treatment with curative intention (118) were included. In 108 cases, the cell cycle was analysed using flow cytometry and double-staining with propidium iodide and anticytokeratin. In another 108 cases, expression of erbB1, erbB2 and P53 was assessed immunhistochemically. Amplification of the erbB family was determined in the tumours of 53 patients using double-differential polymerase chain reaction. Of the tumours, 81% were aneuploid and 14% showed positive staining for erbB1, 18% for erbB2 and 41% for P53. There were normal mean gene copy numbers in 86% for erbB1, 94% for erbB2 and in 96% for erbB3. No significant correlations were noted between erbB1, erbB2 and P53 expression, ploidy status and tumour stage. In a Cox regression model, only tumour stage was shown to be prognostically significant. It seems that ploidy and expression status of erbB1, erbB2 and P53 are not prognostic parameters in non-small cell lung cancer. Amplification of the erbB family does not seem to be a frequent event in non-small cell lung cancer.</description><subject>Adenocarcinoma - genetics</subject><subject>Adenocarcinoma - pathology</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Large Cell - genetics</subject><subject>Carcinoma, Large Cell - pathology</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Carcinoma, Squamous Cell - genetics</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Female</subject><subject>Gene Amplification</subject><subject>Gene Expression</subject><subject>Genes, erbB</subject><subject>Genes, erbB-1</subject><subject>Genes, erbB-2</subject><subject>Genes, p53</subject><subject>Humans</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Ploidies</subject><subject>Pneumology</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Receptor, ErbB-3 - genetics</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>0903-1936</issn><issn>1399-3003</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkE1v1DAQhi0EokvhHyBkCcFpU2bij8RHqPiSKtEDnC3bmbSu8rG1dwX99zi7AS5cPNbomXfsh7GXCBeIrXgHBgQaoS-gNLQyBgEesQ0KYyoBIB6zzYJUC3PGnuV8B4BaCnzKzhBRCQ1qw-6vhzl2D1tOv3aJco7zxOeeU_IfcHss9ZZfK8Hd1HE37obYx-D2_8GOxHITPE58mqcqj24YeKByDIfphgc3BUrP2ZPeDZlerPWc_fj08fvll-rq2-evl--vqiCh2VfeU9uCol52KLxptDRN09VBomgJDXjfSuqC11qQlx2BVp2oFTVQGyMaFOfs7Sl3l-b7A-W9HWNeHuMmmg_ZNrWqZaNUAeUJDGnOOVFvdymOLj1YBLuotn9UWyiNVXUZe7XmH_xI3b-h1W0BXq-Ay8ENfSrfj_kv10rV6rpQb07Ubby5_RkT2aO2EoqW0h1qq2xZKH4DMeKPmw</recordid><startdate>20001101</startdate><enddate>20001101</enddate><creator>Reinmuth, N</creator><creator>Brandt, B</creator><creator>Kunze, WP</creator><creator>Junker, K</creator><creator>Thomas, M</creator><creator>Achatzy, R</creator><creator>Scheld, HH</creator><creator>Semik, M</creator><general>Eur Respiratory Soc</general><general>Maney</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20001101</creationdate><title>Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer</title><author>Reinmuth, N ; Brandt, B ; Kunze, WP ; Junker, K ; Thomas, M ; Achatzy, R ; Scheld, HH ; Semik, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c407t-bbe8805ef4d13b9764977d2c4138e190bb84edcb663eb4de065d325e702993713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adenocarcinoma - genetics</topic><topic>Adenocarcinoma - pathology</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Large Cell - genetics</topic><topic>Carcinoma, Large Cell - pathology</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Carcinoma, Squamous Cell - genetics</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Female</topic><topic>Gene Amplification</topic><topic>Gene Expression</topic><topic>Genes, erbB</topic><topic>Genes, erbB-1</topic><topic>Genes, erbB-2</topic><topic>Genes, p53</topic><topic>Humans</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Ploidies</topic><topic>Pneumology</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Receptor, ErbB-3 - genetics</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reinmuth, N</creatorcontrib><creatorcontrib>Brandt, B</creatorcontrib><creatorcontrib>Kunze, WP</creatorcontrib><creatorcontrib>Junker, K</creatorcontrib><creatorcontrib>Thomas, M</creatorcontrib><creatorcontrib>Achatzy, R</creatorcontrib><creatorcontrib>Scheld, HH</creatorcontrib><creatorcontrib>Semik, M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The European respiratory journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reinmuth, N</au><au>Brandt, B</au><au>Kunze, WP</au><au>Junker, K</au><au>Thomas, M</au><au>Achatzy, R</au><au>Scheld, HH</au><au>Semik, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer</atitle><jtitle>The European respiratory journal</jtitle><addtitle>Eur Respir J</addtitle><date>2000-11-01</date><risdate>2000</risdate><volume>16</volume><issue>5</issue><spage>991</spage><epage>996</epage><pages>991-996</pages><issn>0903-1936</issn><eissn>1399-3003</eissn><abstract>The aim of this study was to assess the prognostic value of deoxyribonucleic acid analysis, expression oferbB1, erbB2 and P53, and amplification levels of erbB1, erbB2 and erbB3 in non-small cell lung cancer (NSCLC). Consecutive patients with NSCLC who underwent treatment with curative intention (118) were included. In 108 cases, the cell cycle was analysed using flow cytometry and double-staining with propidium iodide and anticytokeratin. In another 108 cases, expression of erbB1, erbB2 and P53 was assessed immunhistochemically. Amplification of the erbB family was determined in the tumours of 53 patients using double-differential polymerase chain reaction. Of the tumours, 81% were aneuploid and 14% showed positive staining for erbB1, 18% for erbB2 and 41% for P53. There were normal mean gene copy numbers in 86% for erbB1, 94% for erbB2 and in 96% for erbB3. No significant correlations were noted between erbB1, erbB2 and P53 expression, ploidy status and tumour stage. In a Cox regression model, only tumour stage was shown to be prognostically significant. It seems that ploidy and expression status of erbB1, erbB2 and P53 are not prognostic parameters in non-small cell lung cancer. Amplification of the erbB family does not seem to be a frequent event in non-small cell lung cancer.</abstract><cop>Leeds</cop><pub>Eur Respiratory Soc</pub><pmid>11153605</pmid><doi>10.1183/09031936.00.16599100</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0903-1936 |
| ispartof | The European respiratory journal, 2000-11, Vol.16 (5), p.991-996 |
| issn | 0903-1936 1399-3003 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72524755 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals |
| subjects | Adenocarcinoma - genetics Adenocarcinoma - pathology Adult Aged Biological and medical sciences Carcinoma, Large Cell - genetics Carcinoma, Large Cell - pathology Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Squamous Cell - genetics Carcinoma, Squamous Cell - pathology Female Gene Amplification Gene Expression Genes, erbB Genes, erbB-1 Genes, erbB-2 Genes, p53 Humans Lung Neoplasms - genetics Lung Neoplasms - pathology Male Medical sciences Middle Aged Neoplasm Staging Ploidies Pneumology Prognosis Prospective Studies Receptor, ErbB-3 - genetics Tumors of the respiratory system and mediastinum |
| title | Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T23%3A13%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ploidy,%20expression%20of%20erbB1,%20erbB2,%20P53%20and%20amplification%20of%20erbB1,%20erbB2%20and%20erbB3%20in%20non-small%20cell%20lung%20cancer&rft.jtitle=The%20European%20respiratory%20journal&rft.au=Reinmuth,%20N&rft.date=2000-11-01&rft.volume=16&rft.issue=5&rft.spage=991&rft.epage=996&rft.pages=991-996&rft.issn=0903-1936&rft.eissn=1399-3003&rft_id=info:doi/10.1183/09031936.00.16599100&rft_dat=%3Cproquest_cross%3E72524755%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72524755&rft_id=info:pmid/11153605&rfr_iscdi=true |